Herb Profile

Grapefruit

Botanical profile with evidence, safety, and practical fit.

Last reviewed:

C Preliminary

Use extra caution Major food drug interaction risk: can raise exposure of statins, calcium channel blockers, immunosuppressants, antiarrhythmics, and other CYP3A4/OATP substrates. Details

Evidence
Strong Human Evidence
Typical onset
Varies by prep
Safety rating
High caution
Best for
Digestive, Metabolic health
Avoid / review if
Avoid Or Medically Supervise With Drugs Labeled For Grapefruit Interaction, Narrow Therapeutic Index Drugs, And Complex Cardiovascular/Transplant Regimens.

Monograph visual

Grapefruit

Generated profile category visual

Where to go next — guides & comparisons

Continue reading

  • If you want to browse more herbsAll herbs

Safety & Cautions

Major food drug interaction risk: can raise exposure of statins, calcium channel blockers, immunosuppressants, antiarrhythmics, and other CYP3A4/OATP substrates.

28%

High caution — review carefully

Detailed safety fields

Pregnancy, breastfeeding, and contraindications

  • - Avoid Or Medically Supervise With Drugs Labeled For Grapefruit Interaction
  • - Narrow Therapeutic Index Drugs
  • - And Complex Cardiovascular/Transplant Regimens.
  • - CYP3A4
  • - P Gp
  • - And OATP Mediated Interactions
  • - Effects May Persist Beyond A Single Serving.

Safety classifications

  • - Interaction-Aware: Medication or interaction context is explicitly noted.

Full safety note

  • - Major food drug interaction risk: can raise exposure of statins, calcium channel blockers, immunosuppressants, antiarrhythmics, and other CYP3A4/OATP substrates.

Safety labels

  • - Interaction-Aware

Evidence Summary

Evidence lens

Most useful for practical interpretation when safety context also fits.

StrongStrong Human Evidence

Human clinical evidence: Present in source signals

Mechanistic / preclinical: Mechanism mappedMetabolic Regulation

Research maturity: Preliminary or mixedLong Term Human Evidence May Be Limited.

Safety boundary: Safety note availableMajor food drug interaction risk: can raise exposure of statins, calcium channel blockers, immunosuppressants, antiarrhythmics, and other CYP3A4/OATP substrates.

How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

A

Strong

Multiple RCTs, consistent direction, adequate effect size

B

Moderate

Some RCTs or consistent observational data in humans

C

Preliminary / Mixed

Animal or in-vitro only, or conflicting human data

D

Traditional / Theoretical

Traditional use only; no controlled human trials

Dosing & Timing

Dose guidance

Preparation specific; use standardized product label for Interaction risk varies by whole fruit and require source backed dosage review before therapeutic claims.

How Grapefruit Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Grapefruit Works

How Grapefruit WorksGrapefruit acts on pathways via metabolic (regulation), leading to digestive.GrapefruitBiological pathwayMetabolicRegulationDigestiveObservable outcomeMitochondrialBiogenesis
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways
Preclinical pathways

Proposed mechanisms from in vitro and animal research; these do not confirm clinical outcomes in humans.

Metabolic Regulation

Active Compounds

Key constituents studied in Grapefruit, with full pharmacology and safety profiles.

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Grapefruit

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Free safety checklist

Get the Grapefruit research notes

Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Botanical profile context

How to interpret Grapefruit

Grapefruit dosage ranges, effects, drug interactions, and harm-reduction safety guide for digestive. Strong Human Evidence research evidence. Use this herb profile as a starting point for evidence review, not as a recommendation to start a new supplement. Botanical products can vary by plant part, extract ratio, standardization, dose, and contaminant testing, so two labels with the same common name may not behave the same way.

When reviewing Grapefruit, compare the traditional-use context against the human evidence, mechanism notes, and safety cautions. Pay special attention to pregnancy, breastfeeding, liver or kidney disease, blood-pressure effects, sedation, stimulation, anticoagulant use, antidepressants, and any prescription medication overlap.

For product decisions, prefer transparent labels, named extracts, clear serving sizes, and third-party quality testing. Avoid treating a long list of possible mechanisms as proof that an herb will solve a specific condition.